Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

India's Third Giant Leap

This Leap Could Potentially Generate Gains
Far Bigger than Anything We Have Seen in Our Lifetimes




**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a Free-for-life newsletter from Equitymaster,
which offers the most profitable investing ideas in India.


AD

ZIM LABORATORIES Share Price   (ZIML)



Here is the latest stock price and chart of ZIM LABORATORIES. For more details, see the ZIM LABORATORIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Mar 31, 2023 (Close)
Price (Rs)72.40 Open (Rs) 71.00 High (Rs) 72.60 Low (Rs) 67.45
% Change4.67 Volume 4,139 Value (Rs) 293,871 52-Week H/L 129.33 / 49.08
Live NSE Quotes
Not listed
Change
1 Day
4.67%		1 Month
-8.64%		3 Months
-26.68%		1 Year
-54.71%
Valuation
EPS (Rs)* 4.97 P/E Ratio (x) 14.56 Market Cap (Rs m) 3,527.75 P/BV (x) 1.56 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
  
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

ZIM LABORATORIES Share Price Today:

ZIM LABORATORIES last traded price was up 4.7% to Rs 72.4 on the BSE. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.4%. And the benchmark S&P BSE SENSEX was at 58,991.5 (up 1.8%).

Over the last 30 days, the ZIM LABORATORIES share price is down 8.6%. And over the last one year, ZIM LABORATORIES share price is up 40.2%.

The current market capitalisation of ZIM LABORATORIES stands at Rs 3,527.75 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of December 2022, company promoters held 33.26% stake in ZIM LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of ZIM LABORATORIES.



FAQs on ZIM LABORATORIES

What is the ZIM LABORATORIES share price today?

The last traded price of ZIM LABORATORIES was Rs 72.4 on the BSE, up 4.7% over the previous close.

What is the market cap of ZIM LABORATORIES?

The current market capitalisation of ZIM LABORATORIES stands at Rs 3,528 m.

What is the Earnings per share (EPS) of ZIM LABORATORIES?

ZIM LABORATORIES had an EPS of Rs 5.0 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 1.4.

What is the PE Ratio and PB Ratio of ZIM LABORATORIES?

At the current price of Rs 72.4, ZIM LABORATORIES trades at a PE ratio of 14.56 while its PB ratio stands at 1.56.

What is the Dividend Yield of ZIM LABORATORIES?

For the financial year 2022, ZIM LABORATORIES declared dividend amounting to Rs 0.0 per share. At the current price of Rs 72.4, this results in a dividend yield of 0.0%.


Today's Market

Sensex Today Rallies 1,000 Points | Reliance & Tata Motors Surge 3% | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,000 Points | Reliance & Tata Motors Surge 3% | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on a strong note, Indian share markets continued their momentum throughout the trading session and had their best day in months.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.